COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,692 Articles (22,913 medRxiv, 8,779 bioRxiv)

Most recent first Previous |  Page 2770: Articles 27691-27700  | Next

Modeling the COVID-19 outbreak in Ecuador: Is it the right time to lift social distancing containment measures?
Reina Ortiz, M., Sharma, V.
10.1101/2020.05.21.20109520 — Posted: 2020-05-23
P0: Progress to zero: A simple metric to measure COVID-19 progress by country/region
Lavista Ferres, J. M., Etzioni, R. B., Weeks, W. B.
10.1101/2020.05.21.20109298 — Posted: 2020-05-23
Data driven inference of the reproduction number (R0) for COVID-19 before and after interventions for 51 European countries
Karnakov, P., Arampatzis, G., Kicic, I., Wermelinger, F., Wälchli, D., Papadimitriou, C., Koumoutsakos, P.
10.1101/2020.05.21.20109314 — Posted: 2020-05-23
The connection of growth and medication of COVID-19 affected people after 30 days of lock down in India
Bhattacharyya, A., Bhattacharyya, D., Mukherjee, J.
10.1101/2020.05.21.20107946 — Posted: 2020-05-23
Underreporting of death by COVID-19 in Brazil's second most populous state
Alves, T. H. E., Souza, T. A. d., Silva, S. d. A., Ramos, N. A., Oliveira, S. V. d.
10.1101/2020.05.20.20108415 — Posted: 2020-05-23
Longitudinal laboratory testing tied to PCR diagnostics in COVID-19 patients reveals temporal evolution of distinctive coagulopathy signatures
Pawlowski, C., Wagner, T., Puranik, A., Murugadoss, K., Loscalzo, L., Venkatakrishnan, A., Pruthi, R. K., Houghton, D. E., O'Horo, J. C., Morice, W. G., Halamka, J., Badley, A. D., Barnathan, E. S., Makimura, H., Khan, N., Soundararajan, V.
10.1101/2020.05.21.20109439 — Posted: 2020-05-23
Repurposing Existing Medications for Coronavirus Disease 2019: Protocol for a Rapid and Living Systematic Review
Geisler, B. P., Zahabi, L., Lang, A. E., Eastwood, N., Tennant, E., Lukic, L., Sharon, E., Chuang, H.-H., Kang, C.-B., Clayton-Johnson, K., Aljaberi, A., Yu, H., Bui, C., Le Mau, T., Li, W.-C., Teodorescu, D., Hinske, L. C., Sun, D. L., Manian, F. A., Dunn, A. G.
10.1101/2020.05.21.20109074 — Posted: 2020-05-23
Estimation Of State Variables And Model Parameters For The Evolution Of COVID-19 In The City Of Rio de Janeiro
Orlande, H. R. B., Colaco, M., Dulikravich, G. S., Ferreira, L. F. S.
10.1101/2020.05.21.20108407 — Posted: 2020-05-23
A Systematic Review and Meta-analysis of Therapeutic options against SARS-CoV-2
Thoguluva Chandrasekar, V., Venkatesalu, B., Patel, H. K., Spadaccini, M., Manteuffel, J., Ramesh, M. S.
10.1101/2020.05.20.20108365 — Posted: 2020-05-23
Demographic and Clinical Characteristics of the Severe Covid-19 Infections: First Report from Mashhad University of Medical Sciences, Iran
Goshayeshi, L., Akbari Rad, M., Bergquist, R., Allahyari, A., MUMS Covid-19 Research Team, , Hoseini, B.
10.1101/2020.05.20.20108068 — Posted: 2020-05-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).